{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:33:24Z","timestamp":1790717604591,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.biomaterials.2010.08.076","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T05:21:31Z","timestamp":1285737691000},"page":"214-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids"],"prefix":"10.1016","volume":"32","author":[{"given":"Chun-Ming","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dissaya","family":"Pornpattananangkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Fa","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2010.08.076_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/499632","article-title":"Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002","volume":"193","author":"Kuehnert","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/499367","article-title":"Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003","volume":"42","author":"Klevens","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1090956","article-title":"Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus","volume":"302","author":"Weigel","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib6","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1345\/aph.1L016","article-title":"Ceftobiprole: an extended-spectrum anti-methicillin-resistant Staphylococcus aureus cephalosporin","volume":"42","author":"Anderson","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diagmicrobio.2008.09.001","article-title":"Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin","volume":"63","author":"Bergallo","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.biomaterials.2010.08.076_bib8","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/jac\/dkn250","article-title":"Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study","volume":"62","author":"Florescu","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib9","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1517\/14656566.9.12.2197","article-title":"A new lipoglycopeptide: telavancin","volume":"9","author":"Nannini","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib10","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/IAI.68.6.3200-3209.2000","article-title":"Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections","volume":"68","author":"Burnie","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib11","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1128\/IAI.71.12.6864-6870.2003","article-title":"Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A","volume":"71","author":"Hall","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib12","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1073\/pnas.0402521101","article-title":"Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance","volume":"101","author":"Holden","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10156-007-0551-6","article-title":"Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin","volume":"13","author":"Yanagisawa","year":"2007","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib14","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/ptr.2540","article-title":"Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens against methicillin-resistant Staphylococcus aureus","volume":"23","author":"Cha","year":"2009","journal-title":"Phytother Res"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib15","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1128\/AAC.44.8.2086-2092.2000","article-title":"Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria","volume":"44","author":"Friedrich","year":"2000","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.peptides.2009.06.020","article-title":"In vitro antimicrobial activity of alpha-melanocyte stimulating hormone against major human pathogen Staphylococcus aureus","volume":"30","author":"Madhuri","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/mdr.1998.4.137","article-title":"Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin","volume":"4","author":"Aarestrup","year":"1998","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1194\/jlr.R700016-JLR200","article-title":"Thematic review series: skin lipids - Antimicrobial lipids at the skin surface","volume":"49","author":"Drake","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib19","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1128\/IAI.73.8.4512-4521.2005","article-title":"A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria","volume":"73","author":"Georgel","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1472-765X.2005.01709.x","article-title":"Susceptibility of Clostridium perfringens to C-C fatty acids","volume":"41","author":"Skrivanova","year":"2005","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib21","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1128\/iai.59.12.4332-4337.1991","article-title":"Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 18Z","volume":"59","author":"Chamberlain","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/iai.32.1.98-104.1981","article-title":"Characterization of a bactericidal lipid developing within staphylococcal abscesses","volume":"32","author":"Dye","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nchembio.2007.27","article-title":"Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation","volume":"3","author":"Smith","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425247.5.6.665","article-title":"Novel vesicular and particulate drug delivery systems for topical treatment of acne","volume":"5","author":"Castro","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/15583720701455079","article-title":"Anticancer polymeric nanomedicines","volume":"47","author":"Tong","year":"2007","journal-title":"Polymer Rev"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/092986710790416290","article-title":"Development of nanoparticles for antimicrobial drug delivery","volume":"17","author":"Zhang","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2009.11.033","article-title":"Liposomes as delivery systems for antibiotics","volume":"387","author":"Drulis-Kawa","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2007.05.062","article-title":"Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis","volume":"345","author":"Kisich","year":"2007","journal-title":"Int J\u00a0Pharm"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/1523-1747.ep12611886","article-title":"Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the hamster ear model","volume":"99","author":"Lieb","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib33","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1016\/j.biomaterials.2009.07.033","article-title":"The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes","volume":"30","author":"Yang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1248\/bpb.19.758","article-title":"Effects of liposome size on penetration of dl-tocopherol acetate into skin","volume":"19","author":"Natsuki","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib35","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/nn9018587","article-title":"Stimuli-responsive liposome fusion mediated by gold nanoparticles","volume":"4","author":"Pornpattananangkul","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/08982100903030263","article-title":"Stability evaluation of temoporfin-loaded liposomal gels for topical application","volume":"20","author":"Dragicevic-Curic","year":"2010","journal-title":"J Liposome Res"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2009.10.006","article-title":"Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability","volume":"384","author":"Dragicevic-Curic","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2010.08.076_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1468-3083.2009.03100.x","article-title":"Liposomes in dermatology today","volume":"23","author":"de Leeuw","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961210011142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961210011142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:25:01Z","timestamp":1758900301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961210011142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0142961210011142"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.08.076","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.08.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}